Analyst Ratings for Oramed Pharma (ORMP)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/17/2023 | H.C. Wainwright » Updated 9/9/2024 |
Raghuram Selvaraju | Downgrade | Neutral (Buy) |
N/A (N/A) |
2.25 (3.65) |
62.22% | Details |
| 1/12/2023 | Cantor Fitzgerald | Charles C. Duncan | Downgrade | Neutral (Overweight) |
5.00 (N/A) |
10.79 (3.65) |
-66.17% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


